Literature DB >> 9821045

Calyceal stones: fate of shock wave therapy with respect to stone localization.

A Koşar1, K Türkölmez, K Sarica, Y Z Müftüoğlu, O Gögüş, K Aydos.   

Abstract

In a retrospective analysis the results of extracorporeal shock wave lithotripsy (ESWL) treatment were evaluated in patients with renal stones according to calyceal localization of treated stones. The 198 patients who underwent ESWL with the Dornier MPL 9000 were analyzed for success rate, complication rate, residual fragments, regrowth and recurrence rates. Totally 210 calyceal calculi located in different portions of the kidney have been comparatively evaluated. No major complications were noted during or after ESWL. Some minor complications such as flank pain, renal colic, haematuria were observed. Flank pain was observed during ESWL treatment especially in patients with upper calyceal stones. Although stone-free and residual fragment rates were similar in pelvic, upper and middle calyces, patients with lower calyceal and pelvicalyceal stones had high residual fragment rate and lower stone-free rate. Patients with stones in the lower calyces or pelvicalyces had high recurrence and regrowth rates (p < 0.05). ESWL has been considered as the optimal treatment modality for most upper urinary tract calculi. It is especially effective in patients with pelvic, upper and middle calyceal stones. Patients with lower calyceal stones often failed to eliminate the fragments, hence had high recurrence and regrowth rates.

Entities:  

Mesh:

Year:  1998        PMID: 9821045     DOI: 10.1007/bf02550222

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  9 in total

1.  Report of the United States cooperative study of extracorporeal shock wave lithotripsy.

Authors:  G W Drach; S Dretler; W Fair; B Finlayson; J Gillenwater; D Griffith; J Lingeman; D Newman
Journal:  J Urol       Date:  1986-06       Impact factor: 7.450

2.  Extracorporeal shock wave lithotripsy: the Methodist Hospital of Indiana experience.

Authors:  J E Lingeman; D Newman; J H Mertz; P G Mosbaugh; R E Steele; R J Kahnoski; T A Coury; J R Woods
Journal:  J Urol       Date:  1986-06       Impact factor: 7.450

3.  Long-term stone regrowth and recurrence rates after extracorporeal shock wave lithotripsy.

Authors:  C C Yu; Y H Lee; J K Huang; M T Chen; K K Chen; A T Lin; L S Chang
Journal:  Br J Urol       Date:  1993-11

4.  Extracorporeal shock-wave lithotripsy of kidney and ureteric stones.

Authors:  E Schmiedt; C Chaussy
Journal:  Urol Int       Date:  1984       Impact factor: 2.089

5.  A report on extracorporeal shock wave lithotripsy results on 1,569 renal units in an outpatient clinic.

Authors:  M Tolon; C Miroglu; H Erol; J Tolon; D Acar; E Bazmanoglu; A Erkan; S Amato
Journal:  J Urol       Date:  1991-04       Impact factor: 7.450

6.  Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy.

Authors:  J K Fine; C Y Pak; G M Preminger
Journal:  J Urol       Date:  1995-01       Impact factor: 7.450

7.  Extracorporeal shock-wave lithotripsy for upper urinary tract calculi. One year's experience at a single center.

Authors:  R A Riehle; W R Fair; E D Vaughan
Journal:  JAMA       Date:  1986-04-18       Impact factor: 56.272

8.  The fate of residual fragments after extracorporeal shock wave lithotripsy monotherapy of infection stones.

Authors:  E M Beck; R A Riehle
Journal:  J Urol       Date:  1991-01       Impact factor: 7.450

9.  An evaluation of 646 stone patients treated on the HM4 extracorporeal shock wave lithotriptor.

Authors:  M I Maggio; E R Nicely; D S Peppas; T S Gormley; C E Brown
Journal:  J Urol       Date:  1992-09       Impact factor: 7.450

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.